Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06268015
Title Botensilimab and Balstilimab Optimization in Colorectal Cancer (BBOpCo)
Acronym BBOpCo
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nicholas DeVito, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field